Posted on 11/13/19
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
No matter how you look at it, Bristol-Myers Squibb (NYSE:BMY) claims an attractive dividend. Its yield currently stands north of 2.8%. The big pharma company has . . .
Posted on 11/13/19
ImmunoGen: Profiting And Turning Around
SummaryThis year, ImmunoGen suffered multiple setbacks, both from the clinical and regulatory fronts. Amid these difficulties, there are stellar opportunities to capture mega-profits.ImmunoGen gambled with FORWARD . . .
Posted on 11/12/19
Owl Labs Named As CES 2020 Innovation Awards Winner
Owl Labs, the leader in immersive video conferencing technology and services, today announced that it has been named a CES 2020 Innovation Awards Winner for the . . .
Posted on 11/12/19
eClinicalWorks & healow Announce Collaboration With Humana, GuideWell, & Trusted Health Plan
WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks, a leader in healthcare IT solutions, today announces a collaboration with Humana Inc., a leading health and well-being company, GuideWell, the parent to . . .
Posted on 11/12/19
AVEO Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today reported financial results for the third quarter ended September 30, 2019 and provided a business update.“This quarter we have . . .
Posted on 11/12/19
Akebia Secures $100 Million Non-Dilutive Term Loan Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today reported . . .
Posted on 11/12/19
Better Buy: Biogen vs. Celgene
You probably won't find two bigger stories in the world of biotech in 2019 than those of Biogen (NASDAQ:BIIB) and Celgene (NASDAQ:CELG). Biogen's lead pipeline candidate, . . .
Posted on 11/12/19
Why Bristol-Myers Squibb Stock Gained 13% in October
What happenedBiopharma titan Bristol-Myers Squibb (NYSE:BMY) saw its shares gain 13% in October, according to data from S&P Global Market Intelligence.What sparked this sizable rally in . . .
Posted on 11/12/19
Here's Why Biogen Stock Shot Up 28% in October
What happenedShares of Biogen (NASDAQ:BIIB), a giant biopharmaceutical operation, jumped after management told investors the company would reboot aducanumab's development. Enthusiasm for a potential new drug . . .
Posted on 11/12/19
CVS Health's Aetna Purchase Is Looking Smarter and Smarter
CVS Health (NYSE:CVS) is a lot more than a pharmacy chain at this point, and it intends to keep increasing its reach. The positive news for . . .
Posted on 11/12/19
Agenus Receives $10M from UroGen Pharma
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that it received . . .
Posted on 11/12/19
Bioasis Completes Financing Transactions
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the . . .
Posted on 11/8/19
Planet Fitness Expands Global Footprint to Australia
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., today announced the Company's international expansion . . .
Posted on 11/8/19
SQZ Biotech and AskBio Announce Research Collaboration
SQZ Biotechnologies (SQZ), and Asklepios BioPharmaceutical, Inc. (AskBio), announced a research collaboration to create tolerizing antigen carriers (TACs) containing AAV (adeno-associated virus) components to solve one . . .
Posted on 11/8/19
Press Ganey Chief Medical Officer, Dr. Thomas H. Lee, Publishes ‘The Good Doctor’
BOSTON--(BUSINESS WIRE)--At a time when physician burnout is one of the biggest threats to the delivery of exceptional health care, Press Ganey Chief Medical Officer, Thomas . . .
Posted on 11/7/19
Jounce Therapeutics Reports Third Quarter 2019 Financial Results
CAMBRIDGE, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 11/7/19
Biogen Is A Buy Regardless Of Aducanumab
SummaryBiogen was undervalued before the aducanumab announcement.If approved by the FDA, aducanumab could generate billions in annual revenue.Biogen's pipeline is broad and deep, so treat it . . .
Posted on 11/7/19
Here's Why CVS Health Stock Marched Higher on Wednesday
What happenedShares of the healthcare conglomerate CVS Health (NYSE:CVS) jumped higher in response to the company's third-quarter earnings release. Beating consensus estimates on the top and . . .
Posted on 11/7/19
Roland E. Vanaria, DDS Joins Newton Dentistry
Effective immediately, Dr. Roland Vanaria will join Newton Dentistry. Dr. Vanaria brings over 40 years of dental experience and a wealth of knowledge to the practice, . . .
Posted on 11/6/19
Cara Therapeutics Reports Third Quarter 2019 Financial Results
STAMFORD, Conn., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to . . .
Posted on 11/6/19
Radius Health Announces Third Quarter 2019 Results and Corporate Update
WALTHAM, Mass, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial and operating results for the third quarter ended September . . .
Posted on 11/6/19
Chiasma Reports Third Quarter 2019 Results
WALTHAM, Mass., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and . . .
Posted on 11/6/19
Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update
WALTHAM, Mass., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics . . .
Posted on 11/6/19
Harvard Bioscience Announces Third Quarter Financial Results
HOLLISTON, Mass., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced financial results for the three and nine months ended September 30, . . .
Posted on 11/6/19
Mersana Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .

